KELSI DILLON: Open Payments
NPI 1598470452 · CROOKSVILLE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$814 in 46 payments from 14 companies in 2025. Trend: 2023 $450 · 2024 $517 · 2025 $814
Food & beverage: $670Education: $144
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $232 |
| Astellas Pharma US Inc | 2 | $115 |
| AstraZeneca Pharmaceuticals LP | 5 | $81 |
| Lilly USA, LLC | 3 | $74 |
| Corcept Therapeutics | 3 | $73 |
| Alkermes, Inc. | 2 | $49 |
| GlaxoSmithKline, LLC. | 2 | $32 |
| Novo Nordisk Inc | 2 | $31 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $28 |
| Viatris Specialty LLC | 1 | $25 |
Products named: QULIPTA, Korlym, VRAYLAR, FARXIGA, ARISTADA, TRELEGY ELLIPTA, AIRSUPRA, CREON.
Industry payments across OH — which companies pay providers there.
